MARKET

RCKT

RCKT

Rocket Pharmaceu
NASDAQ
2.870
+0.060
+2.14%
Opening 15:40 07/16 EDT
OPEN
2.870
PREV CLOSE
2.810
HIGH
2.890
LOW
2.750
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
26.98
52 WEEK LOW
2.190
MARKET CAP
309.21M
P/E (TTM)
-1.0925
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RCKT last week (0707-0711)?
Weekly Report · 2d ago
Rocket Pharmaceuticals Appoints Christopher Stevens as Chief Operating Officer Amid Management Changes
Reuters · 4d ago
Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) should contact Levi & Korsinsky about pending Class Action - RCKT
Barchart · 5d ago
Investors File Securities Class Action Lawsuit Against Rocket Pharmaceuticals Over Alleged Misstatements and Omissions
Reuters · 5d ago
CFO Aaron Ondrey Reports Disposal of Rocket Pharmaceuticals Inc. Common Shares
Reuters · 07/08 20:06
Weekly Report: what happened at RCKT last week (0630-0704)?
Weekly Report · 07/07 10:51
Cautious Hold Rating on Rocket Pharmaceuticals Amid IND Clearance and Clinical Hold Challenges
TipRanks · 07/01 00:25
Rocket Pharmaceuticals receives FDA clearance of RP-A701
TipRanks · 06/30 11:25
More
About RCKT
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company focused on the development of gene therapies for rare and devastating diseases. The Company has two clinical stage and one pre-clinical stage in vivo adeno-associated viral (AAV) programs in the United States, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardiac disorder that is characterized by a progressive loss of cardiac muscle mass, severe right ventricular dilation, dysplasia, fibrofatty replacement of the myocardium and a high propensity to arrhythmias and sudden death (RP-A601), and BAG3 Dilated Cardiomyopathy (BAG3-DCM), which is the most common form of cardiomyopathy and is characterized by progressive thinning of the walls of the heart resulting in enlarged heart chambers that are unable to pump blood.

Webull offers Rocket Pharmaceuticals Inc stock information, including NASDAQ: RCKT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RCKT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RCKT stock methods without spending real money on the virtual paper trading platform.